Tricitrasol Solution
NDC Package 23731-6030-2

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Tricitrasol (trisodium citrate dihydrate) solution is triCitrasol® Anticoagulant Sodium Citrate Concentrate, 46.7% Trisodium Citrate, is an anticoagulant used in granulocytapheresis procedures (granulocyte collection by apheresis). This formulation utilizes a solution delivery system. Marketed by Citra Labs Llc, this product is identified by NDC 23731-6030 and is authorized under FDA application BN010409.

Identification & Billing

NDC Package Code
23731-6030-2
Package Description
25 VIAL, SINGLE-USE in 1 CASE / 30 mL in 1 VIAL, SINGLE-USE (23731-6030-3)
Product Code
23731-6030
11-Digit Billing Format
23731603002

Clinical Specifications

Proprietary Name
Tricitrasol
Non-Proprietary Name
Trisodium Citrate Dihydrate
Substance Name
Trisodium Citrate Dihydrate
Dosage Form
Solution - A clear, homogeneous liquid1 dosage form that contains one or more chemical substances dissolved in a solvent or mixture of mutually miscible solvents.
Administration Route
Extracorporeal - Administration outside of the body.
Active Ingredient(s)
TRISODIUM CITRATE DIHYDRATE 14 g/30mL
Pharmacologic Class
Usage Information
TriCitrasol® Anticoagulant Sodium Citrate Concentrate, 46.7% Trisodium Citrate, is an anticoagulant used in granulocytapheresis procedures (granulocyte collection by apheresis). Just prior to performing granulocytapheresis, aseptically add 30 mL of triCitrasol® to 500 mL of the 6% solution of Hydroxyethyl Starch (HES), e.g. Hespan ® 2-8. Agitate the resultant solution for 1 minute to assure a uniform concentration of anticoagulant. The resultant solution of triCitrasol® and 6% solution of HES contains the following concentration depending upon the volume used: Volume of triCitrasol®Volume of HESTotal VolumeFinal Concentration of triCitrasol®30 mL500 mL (measured from HES bag)530 mL2.6%30 mL558 mL (injected directly into HES bag)588 mL2.4%The triCitrasol®/HES solution is stable for up to 24 hours at room temperature after mixing. Refer to the manufacturer's Operator's Manual of the apheresis medical device for the directions to perform the granulocytapheresis procedure.

Regulatory & Marketing

Labeler Name
Citra Labs Llc
Product Type
Human Prescription Drug
FDA Application #
BN010409
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
07-10-2003
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (23731-6030). Click a package code to view its specific billing and regulatory data.

23731-6030-1
10 VIAL, SINGLE-USE in 1 CASE / 30 mL in 1 VIAL, SINGLE-USE (23731-6030-3)

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 23731-6030-2 identifies a specific commercial package of 25 vial, single-use in 1 case / 30 ml in 1 vial, single-use (23731-6030-3) of Tricitrasol, a human prescription drug labeled by Citra Labs Llc. This solution is formulated for extracorporeal use and contains trisodium citrate dihydrate as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Citra Labs Llc on July 10, 2003. The current certification is valid through December 31, 2026.

How is this Citra Labs Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 23731603002. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
23731-6030-2
11-Digit CMS (5-4-2)
23731-6030-02

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.